BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8766640)

  • 1. [Treatment of hyperactivity and attention deficit with amphetamine. Experience with five adult prisoners].
    Stovner AM; Wyller TB; Skulberg A; Os L; Korsmo G
    Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2002-5. PubMed ID: 8766640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperactivity syndrome is common among prisoners. ADHD not only a pediatric psychiatric diagnosis].
    Dalteg A; Gustafsson P; Levander S
    Lakartidningen; 1998 Jun; 95(26-27):3078-80. PubMed ID: 9679423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modafinil treatment of amphetamine abuse in adult ADHD.
    Mann N; Bitsios P
    J Psychopharmacol; 2009 Jun; 23(4):468-71. PubMed ID: 18562425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant treatment of adult attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Psychiatr Clin North Am; 2004 Jun; 27(2):361-72. PubMed ID: 15064002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit hyperactivity disorder, reading disability, and personality disorders in a prison population.
    Rasmussen K; Almvik R; Levander S
    J Am Acad Psychiatry Law; 2001; 29(2):186-93. PubMed ID: 11471785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention deficit hyperactivity disorder in imprisoned individuals--a review.
    Ghanizadeh A; Mohammadi MR; Akhondzadeh S; Sanaei-Zadeh H
    Psychiatr Danub; 2011 Jun; 23(2):139-44. PubMed ID: 21685851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
    Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
    J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH; Zaw F; Handley SL
    Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood attention deficit hyperactivity disorder and the development of substance use disorders: valid concern or exaggeration?
    Looby A
    Addict Behav; 2008 Mar; 33(3):451-63. PubMed ID: 18037571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.
    Poulton A
    Expert Rev Neurother; 2006 Apr; 6(4):551-61. PubMed ID: 16623654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of mixed amphetamine salts extended release in the treatment of school-aged children with attention-deficit/hyperactivity disorder.
    Donner R; Michaels MA; Ambrosini PJ
    Biol Psychiatry; 2007 Mar; 61(5):706-12. PubMed ID: 16899230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of adult ADHD.
    Dodson WW
    J Clin Psychol; 2005 May; 61(5):589-606. PubMed ID: 15723384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Attention deficit hyperactivity disorder in adults].
    Roizblatt A; Bustamante F; Bacigalupo F
    Rev Med Chil; 2003 Oct; 131(10):1195-201. PubMed ID: 14692312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of untreated ADHD among adults: the role of stimulant medication.
    Goksøyr PK; Nøttestad JA
    Addict Behav; 2008 Feb; 33(2):342-6. PubMed ID: 17920777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults.
    Asherson P
    Expert Rev Neurother; 2005 Jul; 5(4):525-39. PubMed ID: 16026236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-deficit/hyperactivity disorder: a life-span perspective.
    Biederman J
    J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.